EUROPEAN ONCOLOGY LAB AS

ORG. NO. 922204748SANDNESActive

Legetjenester.

Ownership & structure

Largest owners

5 sections

Financial statements

Share capitalNOK 30,0002018–20258 years

Revenue2025

94 k+184.8%

Operating profit2025

42 k+171.2%

Equity2025

−27 k+60.9%

EBITDA2025

42 k+171.2%

Bars show revenue. The line shows what remains as net profit after all costs.

The left side shows assets. The right side shows how they are financed (equity + liabilities). The totals are always equal on both sides.

Assets

Equity + liabilities

How much does the business keep from each krone of revenue? Higher is better.

	2021Download annual accounts 2021 as PDF	2022Download annual accounts 2022 as PDF	2023Download annual accounts 2023 as PDF	2024Download annual accounts 2024 as PDF	2025	Change
Revenue	–	–	–	33 k NOK	94 k NOK	+184.8%
Operating profit	NOK 0	–	–	−59 k NOK	42 k NOK	+171.2%
Net profit	−36 k NOK	NOK 0	NOK 0	−60 k NOK	42 k NOK	+170.0%
Equity	−9 k NOK	−9 k NOK	−9 k NOK	−69 k NOK	−27 k NOK	+60.9%
Total liabilities	22 k NOK	22 k NOK	9 k NOK	124 k NOK	54 k NOK	−56.5%
Operating margin	–	–	–	-178.8%	44.7%	+125.0%
Equity ratio	-69.2%	-69.2%	–	-123.2%	-100.0%	+18.8%